Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 1
1990 2
1991 2
1992 4
1993 4
1994 2
1995 2
1996 1
1997 1
1999 1
2000 1
2002 3
2003 1
2004 3
2005 3
2006 1
2007 1
2008 5
2009 3
2010 1
2011 2
2012 3
2013 5
2014 7
2015 5
2016 4
2017 3
2018 5
2019 2
2021 1
2022 2
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

81 results
Results by year
Filters applied: . Clear all
Page 1
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Among authors: nicholas ap. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
The emerging postural instability phenotype in idiopathic Parkinson disease.
Skidmore FM, Monroe WS, Hurt CP, Nicholas AP, Gerstenecker A, Anthony T, Jololian L, Cutter G, Bashir A, Denny T, Standaert D, Disbrow EA. Skidmore FM, et al. Among authors: nicholas ap. NPJ Parkinsons Dis. 2022 Mar 18;8(1):28. doi: 10.1038/s41531-022-00287-x. NPJ Parkinsons Dis. 2022. PMID: 35304493 Free PMC article.
Neuropeptides and classical transmitters. Localization and interaction.
Hökfelt T, Bean A, Ceccatelli S, Dagerlind A, Elde RP, Goldstein M, Meister B, Melander T, Nicholas AP, Pelto-Huikko M, et al. Hökfelt T, et al. Among authors: nicholas ap. Arzneimittelforschung. 1992 Feb;42(2A):196-201. Arzneimittelforschung. 1992. PMID: 1350196 Review.
Citrullinated proteins in rheumatoid arthritis: crucial...but not sufficient!
Cantaert T, De Rycke L, Bongartz T, Matteson EL, Tak PP, Nicholas AP, Baeten D. Cantaert T, et al. Among authors: nicholas ap. Arthritis Rheum. 2006 Nov;54(11):3381-9. doi: 10.1002/art.22206. Arthritis Rheum. 2006. PMID: 17075816 Free article. Review. No abstract available.
Parkinson's disease severity and use of dopaminergic medications.
Fang JY, Pérez A, Christine CW, Leehey M, Aminoff MJ, Boyd JT, Morgan JC, Dhall R, Nicholas AP, Bodis-Wollner I, Zweig RM, Goudreau JL; NINDS NET-PD Investigators. Fang JY, et al. Among authors: nicholas ap. Parkinsonism Relat Disord. 2015 Mar;21(3):297-9. doi: 10.1016/j.parkreldis.2014.10.016. Epub 2014 Dec 15. Parkinsonism Relat Disord. 2015. PMID: 25541182 Free PMC article.
81 results